THIRD HARMONIC BIO INC (THRD) Stock News
NASDAQ:THRD - Nasdaq - US88427A1079 - Common Stock - Currency: USD
THRD Latest News and Analysis
Tuesday's session: top gainers and losers
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Tuesday's session: gap up and gap down stocks
Let's have a look at the gap up and gap down stocks in today's session.
Which stocks are moving before the opening bell on Tuesday?
As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update
Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference
Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference
SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing...
Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
Third Harmonic Bio Announces Third Quarter 2024 Financial Results
Third Harmonic Bio Announces Third Quarter 2024 Financial Results
THB335 Phase 1 SAD/MAD clinical trial on track to deliver clinical results in 1Q’25 Strong financial position with cash and cash equivalents totaling...
Third Harmonic Bio to Participate in Upcoming Investor Conferences in September
Third Harmonic Bio to Participate in Upcoming Investor Conferences in September
SAN FRANCISCO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on...
Third Harmonic Bio to Participate in Upcoming Investor Conferences
Third Harmonic Bio to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing...
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q2 2024
THRD stock results show that Third Harmonic Bio beat analyst estimates for earnings per share the second quarter of 2024.
Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
THB335 Phase 1 SAD/MAD clinical trial progressing; study now on track to report clinical results in 1Q’25 Strong financial position...
Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing...
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q1 2024
THRD stock results show that Third Harmonic Bio beat analyst estimates for earnings per share the first quarter of 2024.
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
U.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results...
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave...
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q4 2023
THRD stock results show that Third Harmonic Bio beat analyst estimates for earnings per share the fourth quarter of 2023.
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
U.S. IND filed for THB335 with anticipated clinical trial start during 2Q’24
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
SAN FRANCISCO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave...
Third Harmonic appoints Christopher Murphy as CFO (NASDAQ:THRD)
Third Harmonic Bio appoints Christopher Murphy as Chief Financial and Business Officer, signaling progress towards their Phase 1 study on THB335.